Skip to main content
. 2023 Apr 24;11(3):e04152-22. doi: 10.1128/spectrum.04152-22

TABLE 2.

Adverse events during the 12-week study

AEa Result for enrolled UC patients (n = 22)b
Total AEs, n 6
Total SAEs, n (%) 0 (0)
Withdrawal due to FMT-related AE, n (%) 1 (4.5)
Abdominal pain, n (%) 2 (9.1)
Loose stools, n (%) 2 (9.1)
Vomiting, n (%) 0 (0)
Fecal with capsules, n (%) 1 (4.5)
a

AE, adverse event; SAEs, serious adverse events.

b

Data are number of events or number of patients with percentage shown in parentheses.